Alzamend neuro announces pre-ind submission for al001 as a treatment of bipolar disorder, major depressive disorder and post-traumatic stress disorder

Atlanta--(business wire)---- $acad #acimmune--alzamend neuro announces pre-ind submission for al001 as a treatment of bipolar disorder, major depressive disorder and post-traumatic stress disorder
ACAD Ratings Summary
ACAD Quant Ranking